Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women

Israel Medical Association Journal

Volumn 6, Issue 10, 2004, Pages 588-591

  Kahan, Natan R ^a,b   Kahan, Ernesto ^c   Waitman, Dan Andrei ^a   Chinitz, David P ^b  

^a Leumit Health Care Services   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drug utilization; Electronic patient records; Empiric antibiotic treatment; Pharmaco economics; Uncomplicated urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; FOSFOMYCIN; NITROFURANTOIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CALCULATION; CONTROLLED STUDY; COST CONTROL; CYSTITIS; DATA ANALYSIS; DRUG COST; ECONOMIC EVALUATION; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; RECURRENT INFECTION; RISK FACTOR; SAMPLING; URINARY TRACT INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CYSTITIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; NITROFURANTOIN; PRACTICE GUIDELINES; PREMENOPAUSE; URINARY TRACT INFECTIONS;

EID: 5044238403     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nicolle LE. Epidemiology of urinary tract infection. Infect Med 2001;18:153-62.
2. Peterson GM, Stanton LA, Bergin JK, Chapman GA. Improving the prescribing of antibiotics for urinary tract infection. J Clin Pharm Ther 1997;22:147-53.
3. Bacheller CD, Bernstein JM. Urinary tract infections. Med Clin North Am 1997;81(3):719-30.
4. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
5. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
6. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med 2002;113(1A):1-4S.
7. McGarock H. Unjustified antibiotic prescribing in the community: a major determinant of bacterial antimicrobial resistance [Editorial]. Pharmacoepidemiol Drug Safety 2002;11:407-8.
8. Hawkes CA. Antibiotic resistance: a clinician's perspective. Milit Med 2000;165(Suppl 2):43-5.
9. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-81.
10. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
11. National Guidelines Clearinghouse. http://www.guideline.gov/summary/summary. aspx?doc_id=2284&nbr=151O&string=uti. Last accessed 11 June 2004.
12. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm W. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-58.
13. Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. IMAJ 2000;2:426-9.
14. Hooton TM, Levy SB. Confronting the antibiotic resistance crisis: making appropriate therapeutic decisions in community medical practice. http://www.medscape.com/viewprogram/618_pnt. Last accessed 3 August 2002.
15. Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002;34:1165-9.
16. Clinical guidelines for the treatment of common infectious diseases in the community. "General Health Services," November 2000.
17. Waitman ED, Blackman S, Kahan NR, Bar-Yochai A. An analysis of in vitro uropathogen sensitivity data to update the guidelines for the empiric treatment of uncomplicated urinary tract infection in adult women in a managed care setting. Presented at the ISPOR 5th Annual European Congress, Barcelona, November 2003.
18. Kahan E, Kahan NR, Chinitz DP. Urinary tract infection in women - physician's preferences for treatment and adherence to guidelines: a national drug utilization study in a managed care setting. Eur J Clin Pharmacol 2003;59:571-7.
19. Kahan, NR, Chinitz DP, Kahan E. Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis. Pharmacoepidemiol Drug Safety 2004;13:239-42.
20. Kahan NR, Chinitz DP, Kahan E. Longer than recommended empiric antibiotic treatment of urinary tract infection in women: an avoidable waste of money. J Clin Pharm Ther 2004;29:59-63.
21. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002;162:41-7.